US Stock MarketDetailed Quotes

Compass Therapeutics (CMPX)

Watchlist
  • 6.000
  • -0.530-8.12%
Close Apr 17 16:00 ET
  • 5.990
  • -0.010-0.17%
Post 20:01 ET
1.08BMarket Cap-14.29P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Compass Therapeutics (CMPX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-9.56%-49.14M
-44.66%-13.25M
1.83%-10.85M
-10.02%-11.83M
4.90%-13.21M
-10.43%-44.86M
25.84%-9.16M
-86.61%-11.05M
-6.34%-10.75M
-13.57%-13.89M
Net income from continuing operations
-34.66%-66.49M
-4.54%-15.72M
-36.07%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.17%-10.48M
-15.94%-13.08M
-37.64%-10.79M
Depreciation and amortization
-16.03%1.47M
3.06%370K
-20.22%371K
-21.24%367K
-21.38%364K
-7.25%1.75M
-23.29%359K
-0.21%465K
-1.89%466K
-3.74%463K
Change In working capital
321.61%9.18M
-58.72%1.46M
173.59%2.18M
986.36%5.02M
110.04%521K
-42.43%-4.14M
1,917.44%3.54M
-208.04%-2.96M
376.29%462K
6.42%-5.19M
-Change in prepaid assets
205.33%5.12M
157.88%312K
154.33%4.02M
226.21%6.26M
-485.58%-5.48M
-171.83%-4.86M
-136.89%-539K
-56.55%1.58M
-359.57%-4.96M
-274.40%-936K
-Change in payables and accrued expense
129.40%4.43M
-74.48%1.19M
60.20%-1.81M
-120.94%-1.2M
258.96%6.26M
122.82%1.93M
446.21%4.66M
-655.91%-4.54M
479.04%5.75M
21.36%-3.94M
-Change in other current liabilities
69.68%-369K
93.41%-38K
-840.00%-37K
87.38%-41K
20.94%-253K
-1.25%-1.22M
-86.13%-577K
101.66%5K
-9.06%-325K
-9.22%-320K
Cash from discontinued investing activities
Operating cash flow
-9.56%-49.14M
-44.66%-13.25M
1.83%-10.85M
-10.02%-11.83M
4.90%-13.21M
-10.43%-44.86M
25.84%-9.16M
-86.61%-11.05M
-6.34%-10.75M
-13.57%-13.89M
Investing cash flow
Cash flow from continuing investing activities
-299.49%-93.31M
-121.98%-3.38M
-427.92%-95.16M
-198.10%-6.36M
382.70%11.59M
73.45%46.77M
143.43%15.37M
70.20%29.02M
1,071.96%6.48M
-196.02%-4.1M
Net PPE purchase and sale
43.18%-25K
--0
84.09%-7K
--0
---18K
-46.67%-44K
--0
-340.00%-44K
--0
--0
Net investment purchase and sale
-299.25%-93.28M
-121.98%-3.38M
-427.40%-95.15M
-198.10%-6.36M
383.14%11.61M
73.42%46.82M
143.08%15.37M
70.36%29.06M
1,088.26%6.48M
-196.02%-4.1M
Cash from discontinued investing activities
Investing cash flow
-299.49%-93.31M
-121.98%-3.38M
-427.92%-95.16M
-198.10%-6.36M
382.70%11.59M
73.45%46.77M
143.43%15.37M
70.20%29.02M
1,071.96%6.48M
-196.02%-4.1M
Financing cash flow
Cash flow from continuing financing activities
647.54%129.61M
1,230.85%1.06M
6,468,150.00%129.36M
0
-104.68%-815K
490.73%17.34M
40.51%-94K
-109.52%-2K
-99.97%1K
42,419.51%17.43M
Net common stock issuance
661.88%138M
--0
--138M
--0
--0
479.43%18.11M
--0
--0
--0
--18.11M
Proceeds from stock option exercised by employees
--1.28M
----
----
----
----
--0
--0
--0
--0
--0
Net other financing activities
-1,147.10%-9.67M
-125.53%-212K
-431,800.00%-8.64M
--0
-19.85%-815K
-206.32%-775K
40.51%-94K
---2K
--1K
---680K
Cash from discontinued financing activities
Financing cash flow
647.54%129.61M
1,230.85%1.06M
6,468,150.00%129.36M
--0
-104.68%-815K
490.73%17.34M
40.51%-94K
-109.52%-2K
-99.97%1K
42,419.51%17.43M
Net cash flow
Beginning cash position
81.82%44.05M
25.18%46.78M
20.72%23.42M
73.44%41.62M
79.45%44.05M
-30.67%24.23M
22.82%37.37M
0.65%19.4M
-11.22%23.99M
-29.75%24.55M
Current changes in cash
-166.68%-12.84M
-354.65%-15.57M
30.01%23.36M
-326.04%-18.19M
-339.53%-2.44M
279.65%19.26M
198.64%6.11M
61.15%17.97M
44.90%-4.27M
93.00%-554K
End cash Position
-28.22%31.21M
-28.22%31.21M
25.18%46.78M
20.72%23.42M
73.44%41.62M
79.47%43.48M
79.47%43.48M
22.82%37.37M
0.65%19.4M
-11.22%23.99M
Free cash flow
-9.51%-49.17M
-44.66%-13.25M
2.15%-10.86M
-10.02%-11.83M
4.77%-13.23M
-10.46%-44.9M
25.89%-9.16M
-87.04%-11.1M
-6.22%-10.75M
-13.57%-13.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -9.56%-49.14M-44.66%-13.25M1.83%-10.85M-10.02%-11.83M4.90%-13.21M-10.43%-44.86M25.84%-9.16M-86.61%-11.05M-6.34%-10.75M-13.57%-13.89M
Net income from continuing operations -34.66%-66.49M-4.54%-15.72M-36.07%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.17%-10.48M-15.94%-13.08M-37.64%-10.79M
Depreciation and amortization -16.03%1.47M3.06%370K-20.22%371K-21.24%367K-21.38%364K-7.25%1.75M-23.29%359K-0.21%465K-1.89%466K-3.74%463K
Change In working capital 321.61%9.18M-58.72%1.46M173.59%2.18M986.36%5.02M110.04%521K-42.43%-4.14M1,917.44%3.54M-208.04%-2.96M376.29%462K6.42%-5.19M
-Change in prepaid assets 205.33%5.12M157.88%312K154.33%4.02M226.21%6.26M-485.58%-5.48M-171.83%-4.86M-136.89%-539K-56.55%1.58M-359.57%-4.96M-274.40%-936K
-Change in payables and accrued expense 129.40%4.43M-74.48%1.19M60.20%-1.81M-120.94%-1.2M258.96%6.26M122.82%1.93M446.21%4.66M-655.91%-4.54M479.04%5.75M21.36%-3.94M
-Change in other current liabilities 69.68%-369K93.41%-38K-840.00%-37K87.38%-41K20.94%-253K-1.25%-1.22M-86.13%-577K101.66%5K-9.06%-325K-9.22%-320K
Cash from discontinued investing activities
Operating cash flow -9.56%-49.14M-44.66%-13.25M1.83%-10.85M-10.02%-11.83M4.90%-13.21M-10.43%-44.86M25.84%-9.16M-86.61%-11.05M-6.34%-10.75M-13.57%-13.89M
Investing cash flow
Cash flow from continuing investing activities -299.49%-93.31M-121.98%-3.38M-427.92%-95.16M-198.10%-6.36M382.70%11.59M73.45%46.77M143.43%15.37M70.20%29.02M1,071.96%6.48M-196.02%-4.1M
Net PPE purchase and sale 43.18%-25K--084.09%-7K--0---18K-46.67%-44K--0-340.00%-44K--0--0
Net investment purchase and sale -299.25%-93.28M-121.98%-3.38M-427.40%-95.15M-198.10%-6.36M383.14%11.61M73.42%46.82M143.08%15.37M70.36%29.06M1,088.26%6.48M-196.02%-4.1M
Cash from discontinued investing activities
Investing cash flow -299.49%-93.31M-121.98%-3.38M-427.92%-95.16M-198.10%-6.36M382.70%11.59M73.45%46.77M143.43%15.37M70.20%29.02M1,071.96%6.48M-196.02%-4.1M
Financing cash flow
Cash flow from continuing financing activities 647.54%129.61M1,230.85%1.06M6,468,150.00%129.36M0-104.68%-815K490.73%17.34M40.51%-94K-109.52%-2K-99.97%1K42,419.51%17.43M
Net common stock issuance 661.88%138M--0--138M--0--0479.43%18.11M--0--0--0--18.11M
Proceeds from stock option exercised by employees --1.28M------------------0--0--0--0--0
Net other financing activities -1,147.10%-9.67M-125.53%-212K-431,800.00%-8.64M--0-19.85%-815K-206.32%-775K40.51%-94K---2K--1K---680K
Cash from discontinued financing activities
Financing cash flow 647.54%129.61M1,230.85%1.06M6,468,150.00%129.36M--0-104.68%-815K490.73%17.34M40.51%-94K-109.52%-2K-99.97%1K42,419.51%17.43M
Net cash flow
Beginning cash position 81.82%44.05M25.18%46.78M20.72%23.42M73.44%41.62M79.45%44.05M-30.67%24.23M22.82%37.37M0.65%19.4M-11.22%23.99M-29.75%24.55M
Current changes in cash -166.68%-12.84M-354.65%-15.57M30.01%23.36M-326.04%-18.19M-339.53%-2.44M279.65%19.26M198.64%6.11M61.15%17.97M44.90%-4.27M93.00%-554K
End cash Position -28.22%31.21M-28.22%31.21M25.18%46.78M20.72%23.42M73.44%41.62M79.47%43.48M79.47%43.48M22.82%37.37M0.65%19.4M-11.22%23.99M
Free cash flow -9.51%-49.17M-44.66%-13.25M2.15%-10.86M-10.02%-11.83M4.77%-13.23M-10.46%-44.9M25.89%-9.16M-87.04%-11.1M-6.22%-10.75M-13.57%-13.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -